Back
Ovid Therapeutics, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
57
OVID
Ovid Therapeutics, Inc.
Last Price:
$1.57
Seasonality Move:
-8.11%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bearish and OVID is experiencing selling pressure, which indicates risk of future bearish movement.
Ovid Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.66 | Sell |
| 20-day SMA: | 1.65 | Sell |
| 50-day SMA: | 1.54 | Buy |
| 200-day SMA: | 0.95 | Buy |
| 8-day EMA: | 1.63 | Sell |
| 20-day EMA: | 1.64 | Sell |
| 50-day EMA: | 1.52 | Buy |
| 200-day EMA: | 0.82 | Buy |
Ovid Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 45.9 | Sell |
| Chaikin Money Flow: | -838189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.75) | Sell |
| Bollinger Bands (100): | (1.3 - 1.68) | Buy |
Ovid Therapeutics, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ovid Therapeutics, Inc. Stock
Is Ovid Therapeutics, Inc. Stock a Buy?
-
Ovid Therapeutics, Inc. share price is 1.57 while OVID 8-day simple moving average is 1.66, which is a Sell signal.
-
The stock price of OVID is 1.57 while Ovid Therapeutics, Inc. 20-day SMA is 1.65, which makes it a Sell.
-
Ovid Therapeutics, Inc. 50-day simple moving average is 1.54 while OVID share price is 1.57, making it a Buy technically.
-
OVID stock price is 1.57 and Ovid Therapeutics, Inc. 200-day simple moving average is 0.95, creating a Buy signal.
OVID Technical Analysis vs Fundamental Analysis
Buy
57
Ovid Therapeutics, Inc. (OVID)
is a Buy
Is Ovid Therapeutics, Inc. a Buy or a Sell?
-
Ovid Therapeutics, Inc. stock is rated a BuyThe current Ovid Therapeutics, Inc. [OVID] share price is $1.57. The Score for OVID is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Ovid Therapeutics, Inc. Stock Info
Market Cap:
111.8M
Price in USD:
1.57
Share Volume:
838.2K
Ovid Therapeutics, Inc. 52-Week Range
52-Week High:
2.01
52-Week Low:
0.24
Buy
57
Ovid Therapeutics, Inc. (OVID)
is a Buy
Ovid Therapeutics, Inc. Share Price Forecast
-
What is the Ovid Therapeutics, Inc. stock price today?The Ovid Therapeutics, Inc. stock price is 1.57 USD today.
-
Will OVID stock go up or go down?Ovid Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Ovid Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ovid Therapeutics, Inc. is not overvalued.
Is Ovid Therapeutics, Inc. Stock a Buy?
-
Ovid Therapeutics, Inc. share price is 1.57 while OVID 8-day exponential moving average is 1.63, which is a Sell signal.
-
The stock price of OVID is 1.57 while Ovid Therapeutics, Inc. 20-day EMA is 1.64, which makes it a Sell.
-
Ovid Therapeutics, Inc. 50-day exponential moving average is 1.52 while OVID share price is 1.57, making it a Buy technically.
-
OVID stock price is 1.57 and Ovid Therapeutics, Inc. 200-day simple moving average is 0.82, creating a Buy signal.
Fundamental Analysis of Ovid Therapeutics, Inc.
Is Ovid Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.01 per share.
Technical Analysis of Ovid Therapeutics, Inc.
Should I short Ovid Therapeutics, Inc. stock?
-
OVID Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Ovid Therapeutics, Inc. is a Buy
-
Ovid Therapeutics, Inc. Relative Strength Index (RSI) is 45.9, which suggest Ovid Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Ovid Therapeutics, Inc. is (1.53 - 1.75), which suggest Ovid Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Ovid Therapeutics, Inc. is (1.3 - 1.68), which suggest Ovid Therapeutics, Inc. is a Buy
* Ovid Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.